Treace Medical Concepts
TMCI
106 hedge funds and large institutions have $618M invested in Treace Medical Concepts in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 9 closing their positions.
1,923% more call options, than puts
Call options by funds: $13M | Put options by funds: $641K
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
58% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 26
16% more funds holding
Funds holding: 91 → 106 (+15)
2.79% more ownership
Funds ownership: 48.3% → 51.08% (+2.8%)
5% more capital invested
Capital invested by funds: $590M → $618M (+$27.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$8.13M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$8.11M |
| 3 |
PA
Perceptive Advisors
New York
|
+$7.93M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$18.1M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.93M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
-$1.52M |
| 4 |
AR
Advisory Research
Chicago,
Illinois
|
-$1.51M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.47M |
TMCI Hedge Fund Activity: Q4 2022 in Review
106 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q4 2022, worth a combined $618M — up 4.6% from $590M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TMCI positions and 9 closed out — a net gain of 15 holders — while 41 added to existing stakes and 26 trimmed.
The largest buyer was CIBC Private Wealth Group, adding an estimated $8.13M. The largest seller was Janus Henderson Group, cutting an estimated $18.1M.
- 106 institutional investors held Treace Medical Concepts (TMCI) as of Q4 2022, up from 91 in Q3 2022.
- Funds reported $618M of Treace Medical Concepts stock for Q4 2022, up 4.6% quarter-over-quarter.
- 24 funds opened new Treace Medical Concepts positions in Q4 2022 and 9 closed out, a net change of +15 holders.
- The largest Treace Medical Concepts buyer in Q4 2022 was CIBC Private Wealth Group, an estimated $8.13M added.
- The largest Treace Medical Concepts seller in Q4 2022 was Janus Henderson Group, an estimated $18.1M sold.
Based on aggregated 13F filings for Q4 2022.